These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 23953038

  • 1. Specificity profile of venlafaxine and sertraline in major depression: metaregression of double-blind, randomized clinical trials.
    Gibiino S, Marsano A, Serretti A.
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):1-8. PubMed ID: 23953038
    [Abstract] [Full Text] [Related]

  • 2. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
    Banzi R, Cusi C, Randazzo C, Sterzi R, Tedesco D, Moja L.
    Cochrane Database Syst Rev; 2015 May 01; 2015(5):CD011681. PubMed ID: 25931277
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A comparison of the efficacy and tolerability of reboxetine and sertraline versus venlafaxine in major depressive disorder: a randomized, open-labeled clinical trial.
    Yazicioglu B, Akkaya C, Sarandol A, Akgoz S, Saygin Eker S, Kirli S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep 30; 30(7):1271-6. PubMed ID: 16820257
    [Abstract] [Full Text] [Related]

  • 5. A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder.
    Shelton RC, Haman KL, Rapaport MH, Kiev A, Smith WT, Hirschfeld RM, Lydiard RB, Zajecka JM, Dunner DL.
    J Clin Psychiatry; 2006 Nov 30; 67(11):1674-81. PubMed ID: 17196045
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trials.
    Einarson TR, Arikian SR, Casciano J, Doyle JJ.
    Clin Ther; 1999 Feb 30; 21(2):296-308. PubMed ID: 10211533
    [Abstract] [Full Text] [Related]

  • 8. Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.
    Nemeroff CB, Entsuah R, Benattia I, Demitrack M, Sloan DM, Thase ME.
    Biol Psychiatry; 2008 Feb 15; 63(4):424-34. PubMed ID: 17888885
    [Abstract] [Full Text] [Related]

  • 9. Long-term management of major depressive disorder: are differences among antidepressant treatments meaningful?
    Shelton CI.
    J Clin Psychiatry; 2004 Feb 15; 65 Suppl 17():29-33. PubMed ID: 15600379
    [Abstract] [Full Text] [Related]

  • 10. Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.
    Mehtonen OP, Søgaard J, Roponen P, Behnke K.
    J Clin Psychiatry; 2000 Feb 15; 61(2):95-100. PubMed ID: 10732656
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH, Andersen HF, Lam RW.
    J Psychiatry Neurosci; 2006 Mar 15; 31(2):122-31. PubMed ID: 16575428
    [Abstract] [Full Text] [Related]

  • 12. Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
    Citrome L.
    J Affect Disord; 2016 May 15; 196():225-33. PubMed ID: 26938965
    [Abstract] [Full Text] [Related]

  • 13. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
    Bauer M, Tharmanathan P, Volz HP, Moeller HJ, Freemantle N.
    Eur Arch Psychiatry Clin Neurosci; 2009 Apr 15; 259(3):172-85. PubMed ID: 19165525
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: a meta-analysis of randomized clinical trials.
    Vis PM, van Baardewijk M, Einarson TR.
    Ann Pharmacother; 2005 Nov 15; 39(11):1798-807. PubMed ID: 16189284
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of venlafaxine in patients with major depressive disorder who have unsustained or no response to selective serotonin reuptake inhibitors: an open-label, uncontrolled study.
    Kaplan EM.
    Clin Ther; 2002 Jul 15; 24(7):1194-200. PubMed ID: 12182262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.